1h Free Analyst Time
The mRNA synthesis raw material market is forecasted to grow by USD 776.45 mn during 2023-2028, accelerating at a CAGR of 4.93% during the forecast period. The report on the mRNA synthesis raw material market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of chronic and infectious diseases, advancements in mRNA technology, and the advantages of mRNA vaccines.
The MRNA synthesis raw material market is segmented as below:
By Application
- Vaccine production
- Therapeutics production
- Others
By End-user
- Biopharmaceutical and pharmaceutical companies
- CROs and CMOs
- Academic and research institutions
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the MRNA synthesis raw material market covers the following areas:
- mRNA synthesis raw material market sizing
- mRNA synthesis raw material market forecast
- mRNA synthesis raw material market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global mRNA synthesis raw material market: Bayer AG, BioNTech SE, BOCSCI Inc., CELONIC Group, Corden Pharma International GmbH, Creative Biolabs, CureVac AG, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, HONGENE, Jena Bioscience GmbH, Lonza Group Ltd., Maravai LifeSciences Holdings Inc., Merck KGaA, New England Biolabs Inc., Pfizer Inc., Promega Corp., Samsung Electronics Co. Ltd., Thermo Fisher Scientific Inc., and Yeasen Biotechnology Co. Ltd..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is collaborations in biotechnology and manufacturing processes related to mRNA synthesis.'
According to the report, one of the major drivers for this market is the growing prevalence of chronic and infectious diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bayer AG
- BioNTech SE
- BOCSCI Inc.
- CELONIC Group
- Corden Pharma International GmbH
- Creative Biolabs
- CureVac AG
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- HONGENE
- Jena Bioscience GmbH
- Lonza Group Ltd.
- Maravai LifeSciences Holdings Inc.
- Merck KGaA
- New England Biolabs Inc.
- Pfizer Inc.
- Promega Corp.
- Samsung Electronics Co. Ltd.
- Thermo Fisher Scientific Inc.
- Yeasen Biotechnology Co. Ltd.
